XML 38 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (CAD)
In Thousands, unless otherwise specified
Mar. 31, 2012
Mar. 31, 2011
Current assets    
Cash and cash equivalents 1,400 722
Accounts receivable, net (note 7 and 21(d)) 214,129 128,482
Unbilled revenue (note 8) 86,859 102,939
Inventories (note 9) 11,855 7,735
Prepaid expenses and deposits (note 10) 6,315 8,269
Investment in and advances to unconsolidated joint venture (note 11) 1,574 1,488
Deferred tax assets (note 17) 2,991 1,729
Total current assets 325,123 251,364
Property, plant and equipment, net (note 13) 312,775 321,864
Other assets (note 12(a)) 21,743 26,908
Goodwill (note 5) 32,901 32,901
Deferred tax assets (note 17) 57,451 49,920
Total Assets 749,993 682,957
Current liabilities    
Accounts payable 171,130 86,053
Accrued liabilities (note 14) 36,795 32,814
Billings in excess of costs incurred and estimated earnings on uncompleted contracts (note 8) 7,514 2,004
Current portion of long term debt (note 15(a)) 14,402 14,862
Current portion of derivative financial instruments (note 21(a)) 3,220 2,474
Deferred tax liabilities (note 17) 21,512 27,612
Total current liabilities 254,573 165,819
Long term debt (note 15(a)) 300,066 290,801
Derivative financial instruments (note 21(a)) 5,926 9,054
Other long term obligations (note 16(a)) 8,860 25,576
Deferred tax liabilities (note 17) 52,788 44,441
Total liabilities 622,213 535,691
Shareholders' equity    
Common shares (authorized - unlimited number of voting common shares; issued and outstanding - March 31, 2012 - 36,251,006 (March 31, 2011 - 36,242,526) (note 18(a)) 304,908 304,854
Additional paid-in capital 8,711 7,007
Deficit (185,820) (164,536)
Accumulated other comprehensive loss (19) (59)
Total shareholders' equity 127,780 147,266
Total liabilities and shareholders' equity 749,993 682,957
Commitments (note 25)      
Contingencies (note 28)